Sidney Murphy, Author at Oncology Nurse Advisor

Sidney Murphy, Author at Oncology Nurse Advisor https://www.oncologynurseadvisor.com Thu, 04 Jan 2024 20:07:55 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png Sidney Murphy, Author at Oncology Nurse Advisor https://www.oncologynurseadvisor.com 32 32 Radiation-Induced Lung Injury https://www.oncologynurseadvisor.com/home/cancer-types/lung-cancer/radiation-induced-lung-injury/ Tue, 19 Dec 2023 15:30:00 +0000 https://www.oncologynurseadvisor.com/?p=114636 Xiuning Le, MD, PhD, discusses the future of tepotinib in the treatment of NSCLC. Dr Le is an author of a phase 2 study on tepotinib, a highly selective MET inhibitor.

Xiuning Le, MD, PhD, discusses the future of tepotinib in the treatment of NSCLC. Dr Le is an author of a phase 2 study on tepotinib, a highly selective MET inhibitor.

Radiation-induced lung injury (RILI) is a complication of radiation therapy and can develop as radiation pneumonitis or pulmonary fibrosis.]]>